Cargando…
Tocilizumab‐induced cytomegalovirus colitis in a patient with COVID‐19
The authors urge clinicians to observe for early signs of CMV reactivation in patients presenting with gastrointestinal bleeding and intestinal perforation after receiving tocilizumab or other immunosuppressive therapy as a treatment for COVID 19. Early recognition of CMV infection and treatment wil...
Autores principales: | Khatib, Mohamad Y., Shaik, Karimulla S., Ahmed, Amna A., Alwraidat, Mohammad A., Mohamed, Ahmed S., Abou Kamar, Mohamad R., Sharaf Eldean, Mouhammad Z., Aldaraiseh, Bashar K., Nashwan, Abdulqadir J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813092/ https://www.ncbi.nlm.nih.gov/pubmed/33489151 http://dx.doi.org/10.1002/ccr3.3487 |
Ejemplares similares
-
Cryptococcemia in a patient with COVID‐19: A case report
por: Khatib, Mohamad Y., et al.
Publicado: (2020) -
Comparison of the clinical outcomes of non-invasive ventilation by helmet vs facemask in patients with acute respiratory distress syndrome
por: Khatib, Mohamad Y., et al.
Publicado: (2021) -
Managing a patient with bipolar disorder associated with COVID‐19: A case report from Qatar
por: Khatib, Mohamad Y., et al.
Publicado: (2021) -
Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series
por: Shaikh, Nissar, et al.
Publicado: (2021) -
Atypical IgG4‐related disease limited to the sino‐nasal cavity: A case report
por: Shaikh, Ahmed, et al.
Publicado: (2021)